About NeoMedLight
NeoMedLight develops innovative medical devices designed for phototherapy.
The company owns a unique and exclusive technology: the emission of light through woven optical fibers: the Lightex®.
NeoMedLight is committed to the treatment and prevention of oral mucositis and radiodermatitis, a huge unmet clinical need.
Mucositis and radiodermatitis are the most common and debilitating side effects of chemotherapy and radiotherapy reported by cancer patients.
CareMin650™ is an innovative solution leveraging our innovative Lightex® technology indicated for the prevention and treatment of mucositis and dermatitis in cancer patients.
The CareMin650™ system allows patients to be treated safely, with precise control of treatment parameters and in a reproducible and consistent manner independent of the operator.
The CareMin650™ is the latest innovation in Photobiomodulation for the treatment of cancer patients.
|
|
|
1-10 employees
View all NeoMedLight employees
|
|
Medical Equipment Manufacturing
|
|
+33 (0)9 72 48 26 19
|
|
88-90 rue Frédéric Faÿs, Villeurbanne, FR
|
|
2014
|
NeoMedLight Staff Directory
Search NeoMedLight Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
